Clinical trial: Backup with combivir (AZT/3TC) or single dose (Sd) Truvada (FTC/TDF) in order to avoid NNRTI resistance after Sd nevirapine for the prevention of mother-to-child transmission (MTCT)
Phase of Trial: Phase III
Latest Information Update: 25 Feb 2016
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Lamivudine/zidovudine; Nevirapine
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms COMTRU
- 17 Feb 2009 Planned number of patients changed from 300 to 450 as reported by ClinicalTrials.gov.
- 17 Feb 2009 Planned end date changed from 1 Mar 2008 to 1 Nov 2010 as reported by ClinicalTrials.gov.
- 23 Oct 2006 New trial record.